Does Rallies show Form 4 insider transactions for RNA?

Yes. Rallies tracks RNA insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is RNA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for RNA. It does not provide personalized investment advice.

RNA (Atrium Therapeutics, Inc. Common Stock) Stock Analysis - Insider Trades

Atrium Therapeutics, Inc. Common Stock (RNA) is a publicly traded Healthcare sector company. As of September 20, 2026, RNA trades at $8.95 with a market cap of $153.10M and a P/E ratio of -1.80. RNA moved -6.28% today. Year to date, RNA is -87.60%; over the trailing twelve months it is -77.66%. Its 52-week range spans $8.66 to $73.06. Analyst consensus is strong buy with an average price target of $25.00. Rallies surfaces RNA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading RNA stock inside the company?

Rallies tracks RNA insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.

RNA Key Metrics

Key financial metrics for RNA
Metric	Value
Price	$8.95
Market Cap	$153.10M
P/E Ratio	-1.80
EPS	$-4.97
Dividend Yield	0.00%
52-Week High	$73.06
52-Week Low	$8.66
Volume	870.84K
Avg Volume	0
Revenue (TTM)	$18.75M
Net Income	$-684.63M
Gross Margin	0.00%

RNA Analyst Consensus

3 analysts cover RNA: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $25.00.

Common questions about RNA

Who is trading RNA stock inside the company?: Rallies tracks RNA insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
Does Rallies show Form 4 insider transactions for RNA?: Yes. Rallies tracks RNA insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is RNA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for RNA. It does not provide personalized investment advice.